Skip to Late-Breaking Abstracts »

All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Poster Presentation Dates

All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.

Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.


Search word or phrase:

# Type Title Authors Category Keywords
487 Poster Presentation Reasons for not testing for biomarkers in non-small cell lung cancer: A regional comparison of patients in the US and Europe Nikita Sharma; Mahaletchumy Krishnam; Ayse Levent, MSc; Ayse Levent, MSc; Ayse Levent, MSc; Education and Treatment Management Biomarkers; Solid tumors
488 Poster Presentation The impact of education on novel concepts in metastatic melanoma: triplet therapy Kinjal Parikh, PharmD, BCOP; Kinjal Parikh, PharmD, BCOP; Kinjal Parikh, PharmD, BCOP; Sara Fagerlie, PhD; Patrick Kugel, MBA; Richard Caracio, MBA; Ryan J. Sullivan, MD; Education and Treatment Management Checkpoint blockade; Targeted therapy
489 Poster Presentation The impact of education on novel concepts in adjuvant melanoma: a closer look at high risk stage II disease Kinjal Parikh, PharmD, BCOP; Kinjal Parikh, PharmD, BCOP; Kinjal Parikh, PharmD, BCOP; Charlotte Warren; Emily Van Laar, MS; Jason J. Luke, MD; Education and Treatment Management Checkpoint blockade
490 Poster Presentation An immuno-oncology census: assessment of clinician knowledge and educational needs in 2020 Janelle Schrag, MPH; Fitzgerald Draper, MS; Monique Dawkins, EdD, MPA; Lorna Lucas, MSM; Leigh Boehmer, Pharm.D, BCOP; Janelle Schrag, MPH; Education and Treatment Management Bispecifics; CAR T cells; Checkpoint blockade
491 Poster Presentation Developing Educational Materials about Immunotherapy for Patients and Their Caregivers Maria B. Gonzalo; Claire Saxton, MBA; Kirstin Fearnley, MALS; Jenny Karubian, MA; Nick Power, BS; Alyssa Jaisle, PhD; Education and Treatment Management Immune adjuvant; Targeted therapy